BONEH Statistics
Total Valuation
BBS-Bioactive Bone Substitutes Oyj has a market cap or net worth of EUR 6.05 million. The enterprise value is 10.78 million.
Market Cap | 6.05M |
Enterprise Value | 10.78M |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
Earnings Date | Feb 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BBS-Bioactive Bone Substitutes Oyj has 19.85 million shares outstanding. The number of shares has increased by 107.69% in one year.
Shares Outstanding | 19.85M |
Shares Change (YoY) | +107.69% |
Shares Change (QoQ) | +36.14% |
Owned by Insiders (%) | 9.91% |
Owned by Institutions (%) | 12.94% |
Float | 12.71M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 1.63 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.03 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.39, with a Debt / Equity ratio of 147.11.
Current Ratio | 0.39 |
Quick Ratio | 0.39 |
Debt / Equity | 147.11 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -19.68 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -148,192 |
Employee Count | 24 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.52% in the last 52 weeks. The beta is -0.51, so BBS-Bioactive Bone Substitutes Oyj's price volatility has been lower than the market average.
Beta (5Y) | -0.51 |
52-Week Price Change | -28.52% |
50-Day Moving Average | 0.33 |
200-Day Moving Average | 0.41 |
Relative Strength Index (RSI) | 42.01 |
Average Volume (20 Days) | 54,053 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | -15,619 |
Operating Income | -3.38M |
Pretax Income | -3.56M |
Net Income | -3.56M |
EBITDA | -3.17M |
EBIT | -3.38M |
Earnings Per Share (EPS) | -0.21 |
Balance Sheet
The company has 850,000 in cash and 5.58 million in debt, giving a net cash position of -4.73 million or -0.24 per share.
Cash & Cash Equivalents | 850,000 |
Total Debt | 5.58M |
Net Cash | -4.73M |
Net Cash Per Share | -0.24 |
Equity (Book Value) | 3.79M |
Book Value Per Share | 0.19 |
Working Capital | -1.41M |
Cash Flow
Operating Cash Flow | -3.07M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BBS-Bioactive Bone Substitutes Oyj does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -107.69% |
Shareholder Yield | -107.69% |
Earnings Yield | -69.45% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |